A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease ...

An international collaboration led by RIKEN researchers has discovered how unusual spherical structures form in the brains of ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

Email news briefs and event listings to [email protected] or [email protected]. Symphony East holiday luncheon The ...

University of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's ...

Lea en español Older adults whose cholesterol levels fluctuate from year to year may face an increased risk for dementia and cognitive decline compared to people whose cholesterol levels remain more ...

MONTANA - As the holiday season approaches, it is crucial to recognize the difference between stress-induced behavior changes ...

The Hispanic population has one of the highest rates of Alzheimer’s disease. While the population is growing, research is ...

BEAUFORT COUNTY, N.C. (WNCT) — 1,400 beads sit in a jar, representing the number of Beaufort County residents age 65 and up ...

Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...